HOTH Hoth Therapeutics
- 0.8100
- -0.0370-4.37%
- 0.8199
- +0.0099+1.22%
Hoth Therapeutics News
MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000 -- Barrons.com
Sector Update: Health Care Stocks Advance Late Afternoon
Express News | Hoth Therapeutics: Approved Purchase of up to $1 Mln in Bitcoin
Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset
Trending Stocks Today | Tonix Pharmaceuticals Surges 58.63% Post-Market
Express News | Hoth Therapeutics Has Been Granted U.S. Patent No. 12,144,815 Titled "USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE."
Hoth Therapeutics Is Maintained at Buy by D. Boral Capital
Hoth Therapeutics | 10-Q: Q3 2024 Earnings Report
Express News | Hoth Therapeutics: Entered Into at the Market Offering Agreement, May Offer & Sell Shares of Common Stock of up to $2.7 Mln
Express News | Hoth Therapeutics Inc - Notified of Non-Compliance With Nasdaq Minimum Bid Price Requirements
Sector Update: Health Care
Hoth Therapeutics Up 34% on Favorable Early Data for Preclinical Study of Cancer Drug
Express News | Hoth Therapeutics Shares Halted To The Upside; Stock Now Up 21.59%
Express News | Hoth Therapeutics Announces Update on Cancer Therapeutic Ht-Kit Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study
H.C. Wainwright Maintains Hoth Therapeutics(HOTH.US) With Buy Rating, Maintains Target Price $4
Hoth Therapeutics: Advancements in Alzheimer's and Skin Toxicity Therapies Drive Buy Rating
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Hoth Shares Rise After Alzheimer's Treatment Gets Patent
Hoth Therapeutics Shares Are Trading Higher After the Company Was Awarded a US Patent for Its HT-ALZ Alzheimer's Treatment and Announced Plans to Prepare for Clinical Trials to Further Validate Its Efficacy in Humans.
No Data